Metabolic Parameters, Weight Loss, and Comorbidities 4 Years After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy


Lager C. J., Esfandiari N. H., Luo Y., Subauste A. R., Kraftson A. T., Brown M. B., ...More

OBESITY SURGERY, vol.28, no.11, pp.3415-3423, 2018 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 28 Issue: 11
  • Publication Date: 2018
  • Doi Number: 10.1007/s11695-018-3346-1
  • Journal Name: OBESITY SURGERY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.3415-3423
  • Keywords: Obesity, Bariatric surgery, Roux-en-Y gastric bypass, Diabetes mellitus, RANDOMIZED CLINICAL-TRIAL, OBESITY-RELATED COMORBIDITIES, TYPE-2 DIABETES-MELLITUS, ALL-CAUSE MORTALITY, 5-YEAR FOLLOW-UP, BODY-MASS INDEX, BARIATRIC SURGERY, MORBID-OBESITY, CARDIOVASCULAR-DISEASE, MEDICAL THERAPY
  • Istanbul University Affiliated: No

Abstract

Sleeve gastrectomy (LSG) is now the predominant bariatric surgery performed, yet there is limited long-term data comparing important outcomes between LSG and Roux-en-Y gastric bypass (RYGB). This study compares weight loss and impact on comorbidities of the two procedures.